Biodesy raises $20 mln
Biodesy Inc said Sept. 10 that it raised $20 million Series C financing led by Alexandria Venture Investments and supported by existing investors 5AM Ventures, Pfizer Ventures and Roche Venture Fund. Ariel G. Notcovich has also joined Biodesy, a biomolecule characterization company, as CEO. Notcovich previously held scientific leadership positions at Bio-Rad Laboratories Inc.
10 September 2018•4 mins read
